Effect of alternative dosing strategies of pembrolizumab and nivolumab on health-care emissions in the Netherlands: a carbon footprint analysis

https://www.thelancet.com/journals/lanplh/article/PIIS2542-5196(24)00245-6/fulltext?dgcid=hubspot_update_feature_updatealerts_lanplh&utm_campaign=update-lanplh&utm_medium=email&_hsenc=p2ANqtz--KT0SgDVZR4wyK-i42YSpjqNIoBWytPECeW92jB2QXQiL9di0s0JKk6_sIkTmrWay5ccegDlwMiPBrUGOpfVxqs_Klfg&_hsmi=334671760&utm_content=334643840&utm_source=hs_email